IRIS
RASPADORI, DONATELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.750
EU - Europa 2.368
AS - Asia 1.442
SA - Sud America 269
AF - Africa 83
OC - Oceania 6
Totale 6.918
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.688
RU - Federazione Russa 699
SG - Singapore 471
CN - Cina 447
GB - Regno Unito 386
IE - Irlanda 340
IT - Italia 230
BR - Brasile 227
SE - Svezia 194
VN - Vietnam 143
DE - Germania 123
FR - Francia 121
HK - Hong Kong 106
UA - Ucraina 95
FI - Finlandia 69
KR - Corea 66
IN - India 53
ZA - Sudafrica 38
CA - Canada 37
BD - Bangladesh 29
TR - Turchia 23
ES - Italia 20
MX - Messico 19
IQ - Iraq 18
JP - Giappone 18
NL - Olanda 18
PL - Polonia 16
AR - Argentina 15
BE - Belgio 12
CZ - Repubblica Ceca 11
NG - Nigeria 10
AT - Austria 8
KE - Kenya 8
EG - Egitto 7
MA - Marocco 7
PK - Pakistan 7
PY - Paraguay 7
UZ - Uzbekistan 7
AU - Australia 6
JO - Giordania 6
CI - Costa d'Avorio 5
ID - Indonesia 5
SA - Arabia Saudita 5
VE - Venezuela 5
EC - Ecuador 4
IR - Iran 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
CL - Cile 3
DZ - Algeria 3
GR - Grecia 3
KG - Kirghizistan 3
LT - Lituania 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CO - Colombia 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
IL - Israele 2
JM - Giamaica 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 6.918
Salva come PNG Salva come JPEG
Città #
Dublin 338
Southend 320
Singapore 306
Dallas 270
Fairfield 267
Ashburn 236
Moscow 188
San Jose 161
Santa Clara 154
Chandler 152
Beijing 116
Woodbridge 112
Seattle 111
Hong Kong 102
Houston 102
Hefei 98
Wilmington 89
Cambridge 80
Ann Arbor 79
Jacksonville 77
Seoul 66
Munich 59
The Dalles 57
Siena 52
Los Angeles 50
Princeton 45
Ho Chi Minh City 41
Lauterbourg 37
New York 37
Hanoi 35
Helsinki 35
Johannesburg 33
São Paulo 25
Council Bluffs 24
Milan 21
Nanjing 21
San Mateo 21
Orem 20
San Diego 20
Turku 20
Florence 19
Rome 18
Bengaluru 16
Izmir 16
Buffalo 15
Dearborn 15
Boardman 14
Frankfurt am Main 14
London 14
Shanghai 14
Tokyo 14
Chennai 13
Dong Ket 12
Toronto 12
Brussels 11
Redondo Beach 11
Abuja 10
Brno 10
Denver 10
Menlo Park 10
Montreal 10
Warsaw 10
Phoenix 9
San Francisco 9
Shenyang 9
Stockholm 9
Atlanta 8
Brooklyn 8
Chicago 8
Düsseldorf 8
Nanchang 8
Nuremberg 8
Porto Alegre 8
Haiphong 7
Lappeenranta 7
Poplar 7
Tashkent 7
Washington 7
Amman 6
Baghdad 6
Belo Horizonte 6
Cairo 6
Jinan 6
Querétaro 6
Rio de Janeiro 6
Turin 6
Abidjan 5
Biên Hòa 5
Brasília 5
Changsha 5
Columbus 5
Curitiba 5
Da Nang 5
Messina 5
Mexico City 5
Tianjin 5
Vienna 5
City of London 4
Fortaleza 4
Hebei 4
Totale 4.607
Salva come PNG Salva come JPEG
Nome #
Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia 307
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 291
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia 276
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. 272
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients 251
Insight into the behavior of hairy cell leukemia by immunogenetic analysis 241
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 240
Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia 238
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 236
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab 235
A BRAF Negative Classic Hairy Cell Leukemia Patient in Long Lasting Complete Remission after Rituximab and Pentostatin 230
A case of acute myelogenous leukemia: myelodysplastic syndrome with t(2;11)(p21;q23) without MLL rearrangement 225
A t(20;21)(q12;q22.3) in a patient with chronic myelocytic leukemia in blastic phase [3] 212
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma 202
An unusual presentation of chronic B-cell lymphocytic leukaemia 197
Anti CD38 monoclonal antibodies for multiple myeloma treatment 195
Minimal residual disease in multiple myeloma: State of the art and applications in clinical practice 189
Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency 187
Fludarabine in patients with advanced and/or resistant B‐chronic lymphocytic leukemia 185
V-H and V-L genes in hairy cell leukemia reveal a dynamic on-going modification of the surface B-cell receptor 170
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome 167
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 162
Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS) 153
DART4MM: Daratumumab as Consolidation Therapy in Patients who Already Achieved Optimal Response/MRD Positivity by Next Generation Flow (NGF): Preliminary Results of a Phase 2 Multicenter Study 152
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 148
Selection and Transplantation of Autologous Hematopoietic CD34+ Cells for Patients with Multiple Myeloma 145
Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia 138
Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation 136
Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma 135
Trisomy 8 in chronic lymphocytic leukemia: a report of two cases 132
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study 131
Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia 130
Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies 129
“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow 129
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 128
Relationship between immunological response to alpha-IFN treatment in 35 patients with hairy cell leukemia 115
Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study 86
Tp53 disruptions: Is there a marker of poor prognosis in chronic lymphoproliferative disorders? 82
Reply to “Peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia and tyrosine kinase inhibitor response: Questions remain!” 26
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM 16
Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment response 7
Totale 7.026
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 0 45
2021/2022377 26 28 28 66 20 15 12 10 14 41 44 73
2022/2023567 32 59 77 73 53 103 14 69 48 13 23 3
2023/2024556 13 11 57 44 20 139 195 6 2 16 8 45
2024/20251.122 28 42 141 63 124 74 26 49 78 50 137 310
2025/20262.817 209 348 252 446 652 109 299 64 87 185 95 71
Totale 7.026